Aurobindo Strikes Respiratory Deal With Mystery Partner
Development Agreement Involves $25m Upfront Payment, $90m Cost Cap
Aurobindo has revealed details of a product development and commercialization deal that it has struck for multiple respiratory products. However, the identity of its “global pharma major” partner remains a mystery for now.
